Meet Our Board

Class II Nominees for Re-Election at Zevra’s 2023 Annual Meeting of Stockholders

Richard W. Pascoe

Chief Executive Officer & Board Member

Appointed Director in January 2014

Christopher A. Posner

Board Member

Appointed Director in November 2022

David S. Tierney, M.D.

Board Member

Appointed Director in March 2015

200+

Total Years of Critical Experience

~8 Years

Average Board Tenure

Zevra Board Skills & Expertise

Number of Zevra Directors

Biotech / Pharmaceutical Experience

Drug Development

Medical and Scientific

Product Management

Commercial and Marketing Operations

Business Development and M&A Transactions

Finance

Public Company Management and Board Service

Matthew R. Plooster

Chairman of the Board

Appointed Director in March 2011

Travis C. Mickle, Ph.D.

President & Board Member; Co-Founder

Appointed Director in October 2006

Tamara A. (Seymour) Favorito

Board Member & Chair, Audit & Compensation Committees

Appointed Director in August 2021

Joseph B. Saluri

Board Member & Chair, Nominating & Corporate Governance Committee

Appointed Director in January 2014

DO NOT vote for any of the Mangless nominees. Vote “AGAINST” the Mangless Proposal.